Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-02

Clinical Trial Update: Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophrenia [NA]

View source ↗

Summary

A clinical trial evaluating low-intensity focused ultrasound neuromodulation of the mediodorsal thalamus for treatment-resistant schizophrenia is currently susp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Treatment-resistant Schizophrenia | NA | Status: SUSPENDED